Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequency of clonal mast cell diseases among patients presenting with anaphylaxis: A prospective study in 178 patients from 5 tertiary centers in Spain.
González-de-Olano D, Esteban-López MI, Alonso-Díaz-de-Durana MD, González-Mancebo E, Prieto-García A, Gandolfo-Cano M, Mohedano-Vicente E, Balugo-López V, Fiandor A, Mielgo-Ballesteros R, Vega-Castro A, García-Montero A, Orfao A, Escribano L, Álvarez-Twose I. González-de-Olano D, et al. Among authors: escribano l. J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2924-2926.e1. doi: 10.1016/j.jaip.2019.05.027. Epub 2019 May 28. J Allergy Clin Immunol Pract. 2019. PMID: 31146019 No abstract available.
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
González de Olano D, Alvarez-Twose I, Esteban-López MI, Sánchez-Muñoz L, de Durana MD, Vega A, García-Montero A, González-Mancebo E, Belver T, Herrero-Gil MD, Fernández-Rivas M, Orfao A, de la Hoz B, Castells MC, Escribano L. González de Olano D, et al. Among authors: escribano l. J Allergy Clin Immunol. 2008 Feb;121(2):519-26. doi: 10.1016/j.jaci.2007.11.010. Epub 2008 Jan 4. J Allergy Clin Immunol. 2008. PMID: 18177694
Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, Mateo MB, Alonso Díaz de Durana MD, de la Hoz B, Del Pozo Gil MD, Caballero T, Rosado A, Sánchez Matas I, Teodósio C, Jara-Acevedo M, Mollejo M, García-Montero A, Orfao A, Escribano L. Alvarez-Twose I, et al. Among authors: escribano l. J Allergy Clin Immunol. 2010 Jun;125(6):1269-1278.e2. doi: 10.1016/j.jaci.2010.02.019. J Allergy Clin Immunol. 2010. PMID: 20434205
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I, Zanotti R, González-de-Olano D, Bonadonna P, Vega A, Matito A, Sánchez-Muñoz L, Morgado JM, Perbellini O, García-Montero A, De Matteis G, Teodósio C, Rossini M, Jara-Acevedo M, Schena D, Mayado A, Zamò A, Mollejo M, Sánchez-López P, Cabañes N, Orfao A, Escribano L; Spanish Network on Mastocytosis (REMA); Italian Network on Mastocytosis (RIMA). Alvarez-Twose I, et al. Among authors: escribano l. J Allergy Clin Immunol. 2014 Feb;133(2):520-8. doi: 10.1016/j.jaci.2013.06.020. Epub 2013 Aug 6. J Allergy Clin Immunol. 2014. PMID: 23921094
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.
Bonadonna P, Gonzalez-de-Olano D, Zanotti R, Riccio A, De Ferrari L, Lombardo C, Rogkakou A, Escribano L, Alvarez-Twose I, Matito A, Vega A, Passalacqua G. Bonadonna P, et al. Among authors: escribano l. J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):474-8. doi: 10.1016/j.jaip.2013.06.014. Epub 2013 Aug 30. J Allergy Clin Immunol Pract. 2013. PMID: 24565619 Clinical Trial.
Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.
Alvarez-Twose I, González-de-Olano D, Sánchez-Muñoz L, Matito A, Jara-Acevedo M, Teodosio C, García-Montero A, Morgado JM, Orfao A, Escribano L. Alvarez-Twose I, et al. Among authors: escribano l. Int Arch Allergy Immunol. 2012;157(3):275-80. doi: 10.1159/000329856. Epub 2011 Oct 28. Int Arch Allergy Immunol. 2012. PMID: 22042301 Clinical Trial.
Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.
Teodosio C, García-Montero AC, Jara-Acevedo M, Sánchez-Muñoz L, Alvarez-Twose I, Núñez R, Schwartz LB, Walls AF, Escribano L, Orfao A. Teodosio C, et al. Among authors: escribano l. J Allergy Clin Immunol. 2010 Mar;125(3):719-26, 726.e1-726.e4. doi: 10.1016/j.jaci.2009.10.020. Epub 2010 Jan 12. J Allergy Clin Immunol. 2010. PMID: 20061010
Evaluation of the WHO criteria for the classification of patients with mastocytosis.
Sánchez-Muñoz L, Alvarez-Twose I, García-Montero AC, Teodosio C, Jara-Acevedo M, Pedreira CE, Matito A, Morgado JM, Sánchez ML, Mollejo M, Gonzalez-de-Olano D, Orfao A, Escribano L. Sánchez-Muñoz L, et al. Among authors: escribano l. Mod Pathol. 2011 Sep;24(9):1157-68. doi: 10.1038/modpathol.2011.84. Epub 2011 May 6. Mod Pathol. 2011. PMID: 21552214 Free article.
171 results